GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BlackRock Health Sciences Trust II (NYSE:BMEZ) » Definitions » ROE %

BlackRock Health Sciences Trust II (BlackRock Health Sciences Trust II) ROE % : -5.28% (As of Dec. 2023)


View and export this data going back to 1990. Start your Free Trial

What is BlackRock Health Sciences Trust II ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. BlackRock Health Sciences Trust II's annualized net income for the quarter that ended in Dec. 2023 was $-104.80 Mil. BlackRock Health Sciences Trust II's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $1,982.99 Mil. Therefore, BlackRock Health Sciences Trust II's annualized ROE % for the quarter that ended in Dec. 2023 was -5.28%.

The historical rank and industry rank for BlackRock Health Sciences Trust II's ROE % or its related term are showing as below:

BMEZ' s ROE % Range Over the Past 10 Years
Min: -27.1   Med: -2.71   Max: 37.85
Current: 3.48

During the past 4 years, BlackRock Health Sciences Trust II's highest ROE % was 37.85%. The lowest was -27.10%. And the median was -2.71%.

BMEZ's ROE % is ranked worse than
54.28% of 1695 companies
in the Asset Management industry
Industry Median: 4.41 vs BMEZ: 3.48

BlackRock Health Sciences Trust II ROE % Historical Data

The historical data trend for BlackRock Health Sciences Trust II's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BlackRock Health Sciences Trust II ROE % Chart

BlackRock Health Sciences Trust II Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROE %
37.85 -8.93 -27.10 3.52

BlackRock Health Sciences Trust II Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Get a 7-Day Free Trial -21.29 -59.19 6.91 11.88 -5.28

Competitive Comparison of BlackRock Health Sciences Trust II's ROE %

For the Asset Management subindustry, BlackRock Health Sciences Trust II's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BlackRock Health Sciences Trust II's ROE % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BlackRock Health Sciences Trust II's ROE % distribution charts can be found below:

* The bar in red indicates where BlackRock Health Sciences Trust II's ROE % falls into.



BlackRock Health Sciences Trust II ROE % Calculation

BlackRock Health Sciences Trust II's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=69.859/( (2056.419+1907.371)/ 2 )
=69.859/1981.895
=3.52 %

BlackRock Health Sciences Trust II's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Jun. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-104.798/( (2058.608+1907.371)/ 2 )
=-104.798/1982.9895
=-5.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


BlackRock Health Sciences Trust II  (NYSE:BMEZ) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-104.798/1982.9895
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-104.798 / -103.476)*(-103.476 / 2054.514)*(2054.514 / 1982.9895)
=Net Margin %*Asset Turnover*Equity Multiplier
=101.28 %*-0.0504*1.0361
=ROA %*Equity Multiplier
=-5.1 %*1.0361
=-5.28 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-104.798/1982.9895
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-104.798 / -104.798) * (-104.798 / -103.476) * (-103.476 / 2054.514) * (2054.514 / 1982.9895)
= Tax Burden * Pretax Margin % * Asset Turnover * Equity Multiplier
= 1 * 101.28 % * -0.0504 * 1.0361
=-5.28 %

Note: The net income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


BlackRock Health Sciences Trust II ROE % Related Terms

Thank you for viewing the detailed overview of BlackRock Health Sciences Trust II's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


BlackRock Health Sciences Trust II (BlackRock Health Sciences Trust II) Business Description

Traded in Other Exchanges
N/A
Address
100 Bellevue Parkway, Wilmington, DE, USA, 19809
BlackRock Health Sciences Trust II is a closed-end management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.
Executives
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Arthur Philip Steinmetz director 50 HUDSON YARDS, NEW YORK NY 10001
Aaron David Wasserman officer: Chief Compliance Officer 50 HUDSON YARDS, NEW YORK NY 10001
Christopher Accettella other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Lorenzo Flores director 2100 LOGIC DRIVE, SAN JOSE CA 95124
James Phillip Holloman director P.O. BOX 625737, 6800 CINTAS BOULEVARD, CINCINNATI OH 45262
Stayce D. Harris director 1999 S. BASCOM AVE., SUITE 700, CAMPBELL CA 95008
Trent Walker officer: Chief Financial Officer C/O PIMCO, 650 NEWPORT CENTER DRIVE, NEWPORT BEACH CA 92660
Xiang Liu other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Jeffrey Gene Lee other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Frank Fabozzi director 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Robert Glenn Hubbard director 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Robert W Fairbairn director 55 EAST 52ND STREET, NEW YORK NY 10055
Cynthia Egan director 7117 BELLONA AVENUE, BALTIMORE MD 21212